Colossal is a firm focused on bioscience and the de-extinction of species like the woolly mammoth and dodo bird.

Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, raised another $200 million for its research.

We'll do the numbers on tax cuts the Trump administration likely wants to extend. Plus: the science behind bringing back the ...

Perhaps known best for its efforts to bring back the woolly mammoth, Dallas-based Colossal’s core mission is preserving biodiversity—the variety of life in ecosystems. And bio ...

Most of the mammoths died out about 10,000 years ago ... On evolutionary timescales they disappeared only a moment ago, but bringing them back is no easy feat. "We have animal operations ...

Colossal aims to revive the woolly mammoth species ... s better to prevent extinctions in the first place, rather than bring back bio-replicas whose ‘reintroduction’ may have a host of ...

Based on these encouraging results, Lamm says he believes bringing back woolly mammoths is likely to have a similarly positive effect. 'We feel confident that, in general, a more diverse ecosystem ...

Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth.

Launched in 2021, Dallas-based Colossal Biosciences Inc. aims to reintroduce extinct species, some of which date back to the ...

Colossal Biosciences announced Wednesday it had raised $200 million in Series C funding round led by TWG Global for its mission to bring back the woolly mammoth, dodo and thylacine (also commonly ...